Portfolio Bar

BioProcess International Conference & Exposition

BPI Is Engineered to Be Exactly What You Need It to Be…

Register Onsite

Conference: October 04-07, 2016 * Exposition:  October 5-07, 2016 * Boston Convention and Exhibition Center, Boston, MA

navigation

THE Industry Meeting Place to Exchange Real-World Solutions to Improve Speed, Cost and Quality

Conference: October 04-07, 2016 · Exhibition: October 17-19, 2016 · Boston Convention and Exhibition Center · Boston, MA

Scientific Advisory Board

Scientific Advisory Board

BPI 2016 Scientific Advisory Board

Cell Culture & Upstream Processing

Susan Dana Jones, Ph.D., Vice President and Senior Consultant, BioProcess Technology Consultants

Thomas Jostock, Ph.D., New Technologies Network Leader/Novartis Leading Scientist, Novartis, Switzerland

John Moscariello, Ph.D., Vice President, Process Development, CMC Biologics

Alison Porter, Ph.D., Head of Mammalian Cell Culture, R&D, Fujifilm Diosynth Biotechnologies

Charles Sardonini, Ph.D., Director, Process Engineering/Development, Genzyme, a Sanofi Company

Recovery & Purification

Hanne Bak, Ph.D., Senior Director, Purification Development, Regeneron Pharmaceuticals, Inc.

Pete Gagnon, M.S., Head of Downstream Processing, Bioprocessing Technology Institute, Singapore

Uwe Gottschalk, Ph.D., Chief Technology Officer, Pharma Biotech, Lonza, Switzerland

Günter Jagschies, Ph.D., Senior Director, Strategic Customer Relations, Biotechnologies R&D, GE Healthcare Life Sciences, Sweden

Ken Kang, Ph.D., Principal Scientist, Head of Purification R&D, BioProcess Sciences, Eli Lilly and Company

Joseph Martin, Ph.D., Research Fellow, Pfizer, Inc.

James Patch, Ph.D., Senior Engineer, Purification Development, Genentech

Natraj Ram, Ph.D., Associate Director, Purification, Manufacturing Sciences, AbbVie Bioresearch Center

Thomas Ransohoff, Vice President and Senior Consultant, BioProcess Technology Consultants, Inc.

Gregory Zarbis-Papastoitsis, Ph.D., VP of Process and Manufacturing Sciences, Eleven Biotherapeutics

Frank Riske, Ph.D., Consultant, Purification, BioProcess Technology Consultants and Formerly of Genzyme

Analytical, Formulation & Quality

Mark Moody, Ph.D., COO, Immunova

Melissa Morandi, Vice President, Global Quality, Aegerion Pharmaceuticals

Thomas Porter, Ph.D., Senior Director, Analytical R&D, Global Biologics, Pfizer, Inc.

Manasi Puri, Scientist, Biopharmaceutical Technologies, GlaxoSmithKline

Nadine Ritter, Ph.D., President and Analytical Advisor, Global Biotech Experts, LLC

Arvind Srivastava, Ph.D., Director, Formulation Development, ImClone Systems

Johnson Varghese, Ph.D., Senior Director/Head, Analytical Development, Shire

Manufacturing Strategy

Chris Antoniou, MS, Distinguished Engineer, Global Engineering Science, Biogen

Barak Barnoon, Director Process Engineering, Bristol-Myers Squibb

Rajesh G. Beri, Ph.D., Head, Mammalian Manufacturing Research & Technology, Lonza - Portsmouth

Kenneth Green, Ph.D., Head of Manufacturing Science and Technology, Shire

Nathalie Hayduk, Strategic Portfolio Leader, Biosciences Manufacturing Group, Pfizer Inc.

David Pollard, Ph.D., Executive Director, BioProcess Technology & Expression, Merck & Co., Inc.

Richard Reineke, Director, Upstream Manufacturing, Amgen, Inc.

Stephanie Rieder, Ph.D., Senior Scientist III, Global Biologics Department, AbbVie

Jonathan Romero, Ph.D., Associate Director, Operations, Technology, Innovation, Global Engineering, Biogen

Rick St. John, Ph.D., Senior Group Leader, Purification Development, Genentech, Inc.

Ran Zheng, Executive Director, Plant Manager, Amgen Inc.

Drug Product Manufacturing & Fill-Finish Processing

Suketu Desai, Ph.D., Chief Technical Officer and Senior Vice President, Semnur Pharmaceuticals

Kevin Kerls, Senior Manager, Genentech, Inc. - A Member of the Roche Group

Kevin Maloney, Ph.D., Principal Scientist, Technical Development, Biogen

Ganapathy Gopalrathnam, Senior Research Scientist, Bioproduct Pharma Design/Formulations, Eli Lilly & Company

Aastha Puri, Project Manager, Biologics Product Strategy and Operations, Yervoy GO-TeamGlobal Manufacturing and Supply, Bristol-Myers Squibb

Early Stage Biologics and Companies

Susan Dana Jones, Ph.D., Vice President and Senior Consultant, BioProcess Technology Consultants

Neil Schauer, Ph.D., Principal Consultant, Schauer Biologics Consulting

General

Sid Advant, President, Kemwell Biopharma

Joanne Beck, Ph.D., Vice President, Process Development, Shire Human Genetic Therapies

Susan Dexter, Senior Principal Consultant, Latham BioPharm Group

Susan Dana Jones, Ph.D., Vice President and Senior Consultant, BioProcess Technology Consultants

Peter Latham, President, Latham BioPharm Group

Thomas Ransohoff, Vice President and Senior Consultant, BioProcess Technology Consultants, Inc.

Robert Repetto, M.S., MBA, Senior Director, External Affairs, Pfizer

Frank Riske, Ph.D., Consultant, Purification, BioProcess Technology Consultants and Formerly of Genzyme

Charles Sardonini, Ph.D., Director, Process Engineering/Development, Genzyme, a Sanofi Company

Ian Sellick, Director of Marketing, Pall Life Sciences

Gregory Zarbis-Papastoitsis, Ph.D., VP of Process and Manufacturing Sciences, Eleven Biotherapeutics

footer